Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Endocrinology and Metabolism|March 1, 2007
Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell deathConcetta Conticello, Luana Adamo, Raffaella Giuffrida, et al.
Advances in Therapy|October 13, 2025
The Role of Radioligand Therapy in Gastroenteropancreatic Neuroendocrine Tumors: An Italian Expert OpinionSalvatore Tafuto, Secondo Lastoria, Francesco Panzuto, et al.
Biomedicines|August 29, 2024
The Protective Role of Troxerutin (Trox) in Counteracting Anaplastic Thyroid Carcinoma (ATC) ProgressionValentina Bova, Rossella Basilotta, Giovanna Casili, et al.
Leukemia & Lymphoma|April 6, 2004
Fludarabine, mitoxantrone and dexamethasone as front-line therapy in elderly patients affected by newly-diagnosed, low-grade non-Hodgkin's lymphomas with unfavorable prognostic factors: results of a phase II studyRoberto Bordonaro, Giuseppina Petralia, Nunzio Restuccia, et al.
Frontiers in Endocrinology|February 16, 2023
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysisIvana Puliafito, Federico Chillari, Alessandro Russo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2011
Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancerVienna Ludovini, Fortunato Bianconi, Lorenza Pistola, et al.
International Journal of Oncology|April 11, 2017
MicroRNA-based molecular classification of papillary thyroid carcinomaFrancesca Rosignolo, Lorenzo Memeo, Fabio Monzani, et al.
Cancers|July 12, 2025
Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE StudyGiuseppina Rosaria Rita Ricciardi, Alessandro Russo, Maria Vita Sanò, et al.
Ecancermedicalscience|November 4, 2020
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysisVittorio Gebbia, Marco Maria Aiello, Giuseppe Banna, et al.
Journal of Cancer Research and Clinical Oncology|February 20, 2017
Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE studyMaria Rita Migliorino, Antonio Santo, Giampiero Romano, et al.
Pageof 7